ERBB2 and breast carcinoma: With the above discussion on the molecular type of breast cancer versus topoisomerase II alpha expression according to Romero A et al [17], high-proliferative subtypes, such as Basal-like, Luminal B, and HER2-enriched, expressed higher levels of topoisomerase II alpha than Luminal A.